Delivery Order 75N91018D00022-75N91024F00001

Award Date 9/27/24
Potential Completion Date 9/19/27
Potential Value $4M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Sioux Falls, SD 57104, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
4
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Sanford Research, a non-profit research organization based in Sioux Falls, South Dakota. The award is a delivery order under an indefinite-delivery, indefinite-quantity (IDIQ) contract for "Cancer Study Cohort Recruitment" from the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH). The task order, valued at $4,786,893.00, funds preparation and study launch activities, continued infrastructure setup, and other...
This is a task order awarded under the Cancer Study Cohort Recruitment master indefinite-delivery, indefinite-quantity (IDIQ) contract held by the National Institutes of Health (NIH) National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services (HHS). The task order, valued at $289,160.29, was awarded to Sanford Research, a non-profit organization and foundation focused on biomedical research. The task order is for study planning and preparation services,...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a firm fixed price purchase order contract to Sanford Research North, a non-profit organization, on September 13, 2017. The potential value of the contract is $118,660.08, and the completion date is November 10, 2017. The contract does not have a set-aside designation. Sanford Research North provides healthcare and biomedical research services, and has previously conducted federal...
This is a $547,860 delivery order contract awarded by the National Cancer Institute (NCI) of the Department of Health and Human Services (HHS) to The Institute for Cancer Research, a non-profit research organization. The contract is part of the Preclinical Efficacy and Intermediate Endpoint Biomarkers indefinite delivery vehicle, which supports the PREVENT Cancer Preclinical Drug Development Program. Under this 5-year IDIQ, The Institute for Cancer Research provides preclinical efficacy...
This is a firm fixed price delivery order contract awarded to the Fred Hutchinson Cancer Research Center, a non-profit organization, by the Department of Health and Human Services' National Institutes of Health National Cancer Institute. The contract is for the Patterns of Care (POC)/Quality of Care Study, which will analyze non-small cell lung cancer (NSCLC) diagnosis data from 2017 and NSCLC and melanoma diagnosis data from 2018. The contract has a potential value of $85,626.00 and was awarded...
This is a $29,760,269.00 definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. government, to the National Opinion Research Center (NORC), a non-profit research organization. The contract is for support services to establish and study a prospective U.S. cohort within healthcare systems to research cancer. This contract is not set aside for small businesses. NORC, the prime contractor, has a history of providing comprehensive survey research, data...
This $11,541,930.00 delivery order contract was awarded by the National Cancer Institute (NCI), a civilian agency within the National Institutes of Health (NIH), to the University of Chicago. The contract supports the "PREPARATION AND STUDY LAUNCH" for a Cancer Study Cohort Recruitment effort, which is the parent indefinite delivery/indefinite quantity (IDIQ) contract vehicle. The award has a period of performance through July 6, 2025 and does not have a set-aside designation. The...
The National Cancer Institute (NCI) awarded a $3,212,212 delivery order to the Fred Hutchinson Cancer Research Center, a non-profit organization, to provide core infrastructure support services. This award was not set aside and is part of the NCI's Surveillance, Epidemiology, and End Results (SEER) program, which conducts cancer research and patient care. The contract has a period of performance through May 31, 2014 and is a cost-no-fee type. Fred Hutchinson has held other federal contracts...
This is a Cost Plus Fixed Fee contract awarded by the National Cancer Institute (NCI), a civilian agency of the U.S. government, to Southern Research Institute, a non-profit research organization. The contract, valued at $23,192,206.83, is for preclinical pharmacology and toxicology studies. It does not have a set-aside designation. Southern Research Institute has a history of providing a range of research and development services to federal agencies, including drug discovery and development...
This is a $39,011,179.48 cost-plus-fixed-fee delivery order contract awarded to Leidos Biomedical Research Inc. by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), for the development of target characterization methods for novel cancer markers. The contract supports the President's Department of Government Efficiency Cost Efficiency Initiative. It does not have a set-aside designation. Leidos Biomedical Research Inc. is a subsidiary of Leidos Holdings,...

This is a $4,023,281.00 delivery order contract awarded to Sanford Research, a non-profit biomedical research organization, by the National Cancer Institute (NCI). The contract is part of a larger "Cancer Study Cohort Recruitment" indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle. The work involves preparing and launching cancer research studies, developing research infrastructure, and supporting cohort recruitment activities. The contract does not have a set-aside designation, indicating open competition. Sanford Research has demonstrated capabilities in areas such as cancer biology, pediatric research, cellular and molecular biology, and medical genetics, and has a history of securing significant federal grant awards from agencies like the National Institutes of Health and National Science Foundation for various research initiatives.

Generated 9/11/25, 10:48 AM